Bausch + Lomb [BLCO] vs Align Technology [ALGN] Detailed Stock Comparison

Bausch + Lomb

NYSE
Loading...

Align Technology

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Bausch + Lomb wins in 8 metrics, Align Technology wins in 11 metrics, with 0 ties. Align Technology appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBausch + LombAlign TechnologyBetter
P/E Ratio (TTM)-16.8922.33Bausch + Lomb
Price-to-Book Ratio0.842.45Bausch + Lomb
Debt-to-Equity Ratio76.203.14Align Technology
PEG Ratio0.290.65Bausch + Lomb
EV/EBITDA19.1311.01Align Technology
Profit Margin (TTM)-5.58%11.04%Align Technology
Operating Margin (TTM)0.86%16.10%Align Technology
EBITDA Margin (TTM)0.86%16.10%Align Technology
Return on Equity-4.02%11.41%Align Technology
Return on Assets (TTM)0.47%6.50%Align Technology
Free Cash Flow (TTM)$-59.00M$622.65MAlign Technology
1-Year Return-23.52%-40.78%Bausch + Lomb
Price-to-Sales Ratio (TTM)1.102.42Bausch + Lomb
Enterprise Value$10.14B$8.80BBausch + Lomb
EV/Revenue Ratio2.072.22Bausch + Lomb
Gross Profit Margin (TTM)58.92%69.94%Align Technology
Revenue per Share (TTM)$14$54Align Technology
Earnings per Share (Diluted)$-0.78$5.92Align Technology
Beta (Stock Volatility)0.631.70Bausch + Lomb
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bausch + Lomb vs Align Technology Stock Performance Analysis

Loading Price Chart...

Bausch + Lomb
Align Technology
Bausch + Lomb Stock Overview | Align Technology Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bausch + Lomb-1.54%-0.47%-4.06%7.82%25.44%-17.28%
Align Technology-0.78%4.06%-3.92%-32.16%-14.25%-36.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bausch + Lomb-23.52%1.36%192.53%87.30%54.94%54.94%
Align Technology-40.78%-34.78%-60.92%116.82%542.09%1,773.22%

News Based Sentiment: Bausch + Lomb vs Align Technology

Bausch + Lomb

News based Sentiment: MIXED

October presented a mixed bag for Bausch + Lomb, with a neutral analyst rating and some institutional selling offset by positive earnings, insider buying, and continued investment in promising biotech solutions. While not a dramatically positive or negative month, the developments warrant close attention from investors.

View Bausch + Lomb News Sentiment Analysis

Align Technology

News based Sentiment: NEGATIVE

October proved to be a difficult month for Align Technology, with disappointing Q2 earnings, lowered guidance, and a legal investigation overshadowing positive developments like the share buyback and CEO purchase. The mixed institutional activity and cautious analyst outlook reflect the uncertainty surrounding the company's future performance.

View Align Technology News Sentiment Analysis

Performance & Financial Health Analysis: Bausch + Lomb vs Align Technology

MetricBLCOALGN
Market Information
Market Cap i$5.39B$9.65B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i575,2301,159,030
90 Day Avg. Volume i535,0331,245,877
Last Close$14.66$130.47
52 Week Range$10.45 - $21.69$122.00 - $246.19
% from 52W High-32.41%-47.00%
All-Time High$21.95 (Jun 26, 2023)$737.45 (Sep 20, 2021)
% from All-Time High-33.21%-82.31%
Growth Metrics
Quarterly Revenue Growth0.05%-0.02%
Quarterly Earnings Growth0.05%0.29%
Financial Health
Profit Margin (TTM) i-0.06%0.11%
Operating Margin (TTM) i0.01%0.16%
Return on Equity (TTM) i-0.04%0.11%
Debt to Equity (MRQ) i76.203.14
Cash & Liquidity
Book Value per Share (MRQ)$18.20$53.98
Cash per Share (MRQ)$0.75$12.43
Operating Cash Flow (TTM) i$186.00M$731.07M
Levered Free Cash Flow (TTM) i$57.63M$676.43M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Bausch + Lomb vs Align Technology

MetricBLCOALGN
Price Ratios
P/E Ratio (TTM) i-16.8922.33
Forward P/E i12.7712.88
PEG Ratio i0.290.65
Price to Sales (TTM) i1.102.42
Price to Book (MRQ) i0.842.45
Market Capitalization
Market Capitalization i$5.39B$9.65B
Enterprise Value i$10.14B$8.80B
Enterprise Value Metrics
Enterprise to Revenue i2.072.22
Enterprise to EBITDA i19.1311.01
Risk & Other Metrics
Beta i0.631.70
Book Value per Share (MRQ) i$18.20$53.98

Financial Statements Comparison: Bausch + Lomb vs Align Technology

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BLCOALGN
Revenue/Sales i$1.28B$1.01B
Cost of Goods Sold i$525.00M$304.33M
Gross Profit i$753.00M$708.12M
Research & Development i$96.00M$96.40M
Operating Income (EBIT) i$11.00M$163.03M
EBITDA i$99.00M$203.61M
Pre-Tax Income i$-147.00M$173.52M
Income Tax i$-89.00M$48.91M
Net Income (Profit) i$-58.00M$124.61M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BLCOALGN
Cash & Equivalents i$202.00M$901.16M
Total Current Assets i$2.69B$2.45B
Total Current Liabilities i$1.73B$2.00B
Long-Term Debt i$4.79B$90.47M
Total Shareholders Equity i$6.43B$3.91B
Retained Earnings i$-783.00M$2.43B
Property, Plant & Equipment iN/A$1.38B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BLCOALGN
Operating Cash Flow i$-32.00M$93.23M
Capital Expenditures i$-110.00M$-21.48M
Free Cash Flow i$-135.00M$107.17M
Debt Repayment i$-10.00MN/A
Common Stock Repurchase iN/A$-96.05M

Short Interest & Institutional Ownership Analysis

MetricBLCOALGN
Shares Short i3.22M2.23M
Short Ratio i6.331.73
Short % of Float i0.08%0.04%
Average Daily Volume (10 Day) i575,2301,159,030
Average Daily Volume (90 Day) i535,0331,245,877
Shares Outstanding i352.40M73.85M
Float Shares i42.13M67.96M
% Held by Insiders i0.88%0.07%
% Held by Institutions i0.11%0.94%

Dividend Analysis & Yield Comparison: Bausch + Lomb vs Align Technology

MetricBLCOALGN
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A